Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response / Bonifacio, M; Binotto, G; Maino, E; Calistri, E; Marin, L; Scaffidi, L; Frison, L; De Marchi, F; Krampera, M; Semenzato, G; Fanin, Renato; Ambrosetti, A; Tiribelli, Mario. - In: HAEMATOLOGICA. - ISSN 1592-8721. - (2015).
Titolo: | Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response. |
Autori: | |
Data di pubblicazione: | 2015 |
Rivista: | |
Handle: | http://hdl.handle.net/11390/1071149 |
Appare nelle tipologie: | 1.1 Articolo in rivista |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
83. haematologica 2015 (1).pdf | Versione Editoriale (PDF) | ![]() | Open Access Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.